BBNX fundamentals
An in-depth look to Beta Bionics, Inc. operating, investing, and financing activities
BBNX free cash flow for Q4 24 is -14.84 M USD. For 2024, BBNX free cash flow was -51.67 M USD and operating cash flow was -48.27 M USD.
Q3 '23
Q4 '23
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '23
Q4 '23
Q3 '24
Q4 '24
TTM